AAAAAA
Results: 1-25/178
Authors:
TARNOW L
GLUUD C
PARVING HH
Citation: L. Tarnow et al., DIABETIC NEPHROPATHY AND THE INSERTION DELETION POLYMORPHISM OF THE ANGIOTENSIN-CONVERTING ENZYME GENE/, Nephrology, dialysis, transplantation, 13(5), 1998, pp. 1125-1130
Authors:
DEINUM J
TARNOW L
VANGOOL J
DERKX F
DEBRUIN R
SCHALEKAMP M
PARVING HH
Citation: J. Deinum et al., PLASMA-RENIN AND PRORENIN AND RENIN GENE VARIATION IN PATIENTS WITH INSULIN-DEPENDENT DIABETES-MELLITUS AND NEPHROPATHY, Journal of hypertension, 16, 1998, pp. 431-431
Authors:
PARVING HH
Citation: Hh. Parving, BENEFITS AND COST OF ANTIHYPERTENSIVE TREATMENT IN INCIPIENT AND AVERT DIABETIC NEPHROPATHY, Journal of hypertension, 16, 1998, pp. 99-101
Authors:
PARVING HH
Citation: Hh. Parving, IS ANTIHYPERTENSIVE TREATMENT THE SAME FOR NIDDM AND IDDM PATIENTS, Diabetes research and clinical practice, 39, 1998, pp. 43-47
Authors:
SATO A
TARNOW L
PARVING HH
Citation: A. Sato et al., INCREASED LEFT-VENTRICULAR MASS IN NORMOTENSIVE TYPE-1 DIABETIC-PATIENTS WITH DIABETIC NEPHROPATHY, Diabetes care, 21(9), 1998, pp. 1534-1539
Authors:
NIELSEN FS
SATO A
ALI S
TARNOW L
SMIDT UM
KASTRUP J
PARVING HH
Citation: Fs. Nielsen et al., BENEFICIAL IMPART OF RAMIPRIL ON LEFT-VENTRICULAR HYPERTROPHY IN NORMOTENSIVE NONALBUMINURIC NIDDM PATIENTS, Diabetes care, 21(5), 1998, pp. 804-809
Authors:
ROSSING K
JACOBSEN P
ROSSING P
LAURITZEN E
LUNDANDERSEN H
PARVING HH
Citation: K. Rossing et al., IMPROVED VISUAL FUNCTION IN IDDM PATIENTS WITH UNCHANGED CUMULATIVE INCIDENCE OF SIGHT-THREATENING DIABETIC-RETINOPATHY, Diabetes care, 21(11), 1998, pp. 2007-2015
Authors:
PARVING HH
ROSSING P
Citation: Hh. Parving et P. Rossing, DIABETES AND RISK OF ADVERSE EVENTS WITH CALCIUM-ANTAGONISTS, Diabetes care, 21(10), 1998, pp. 1779-1780
Authors:
PARVING HH
Citation: Hh. Parving, HYPERTENSION OPTIMAL TREATMENT (HOT) TRIAL, Lancet, 352(9127), 1998, pp. 574-574
Authors:
JACOBSEN P
ROSSING K
ROSSING P
TARNOW L
MALLET C
POIRIER O
CAMBIEN F
PARVING HH
Citation: P. Jacobsen et al., ANGIOTENSIN-CONVERTING ENZYME GENE POLYMORPHISM AND ACE-INHIBITION INDIABETIC NEPHROPATHY, Kidney international, 53(4), 1998, pp. 1002-1006
Authors:
HANSEN HP
ROSSING P
MATHIESEN ER
HOMMEL E
SMIDT UM
PARVING HH
Citation: Hp. Hansen et al., ASSESSMENT OF GLOMERULAR-FILTRATION RATE IN DIABETIC NEPHROPATHY USING THE PLASMA-CLEARANCE OF CR-51-EDTA, Scandinavian journal of clinical & laboratory investigation, 58(5), 1998, pp. 405-413
Authors:
PARVING HH
Citation: Hh. Parving, RENOPROTECTION IN DIABETES - GENETIC AND NONGENETIC RISK-FACTORS AND TREATMENT, Diabetologia, 41(7), 1998, pp. 745-759
Authors:
GAEDE P
VEDEL P
PARVING HH
PEDERSEN O
Citation: P. Gaede et al., THE STENO TYPE-2 STUDY - INTENSIVE MULTIFACTORIAL INTERVENTION DELAYSPROGRESSION IN DIABETIC MICROANGIOPATHY AND MACROANGIOPATHY IN MICROALBUMINURIC TYPE-2 DIABETIC-PATIENTS, Diabetologia, 41, 1998, pp. 7-7
Authors:
ROSSING K
JACOBSEN P
HOMMEL E
MATHIESEN E
SVENNINGSEN A
ROSSING P
PARVING HH
Citation: K. Rossing et al., THE INFLUENCE OF PREGNANCY ON RENAL-FUNCTION LOSS IN INSULIN-DEPENDENT DIABETIC-PATIENTS WITH DIABETIC NEPHROPATHY, Diabetologia, 41, 1998, pp. 22-22
Authors:
ROSSING P
BREUM L
MAJORPEDERSEN A
SATO A
WINDING H
PIETERSEN A
KASTRUP J
PARVING HH
Citation: P. Rossing et al., QT INTERVAL PREDICTS MORTALITY IN TYPE-I DIABETIC-PATIENTS, Diabetologia, 41, 1998, pp. 109-109
Authors:
CHRISTENSEN PK
GAIL MA
PARVING HH
Citation: Pk. Christensen et al., THE COURSE OF GLOMERULAR-FILTRATION RATE IN ALBUMIN URIC NON-INSULIN-DEPENDENT DIABETIC-PATIENTS WITH OR WITHOUT DIABETIC GLOMERULOPATHY, Diabetologia, 41, 1998, pp. 1113-1113
Authors:
TARNOW L
FAGERUD J
ROSSING P
NIELSEN FS
CAMBIEN F
PARVING HH
Citation: L. Tarnow et al., CARDIOVASCULAR MORBIDITY AND EARLY MORTALITY CLUSTERS IN PARENTS OF IDDM PATIENTS WITH DIABETIC NEPHROPATHY, Diabetologia, 41, 1998, pp. 1125-1125
Authors:
SATO A
TARNOW L
PARVING HH
Citation: A. Sato et al., PREVALENCE OF LEFT-VENTRICULAR HYPERTROPHY IN TYPE-1 DIABETIC-PATIENTS WITH DIABETIC NEPHROPATHY, Diabetologia, 41, 1998, pp. 1127-1127
Authors:
JACOBSEN P
ROSSING K
TARNOW L
ROSSING P
MALLET C
POIRIER O
CAMBIEN F
PARVING HH
Citation: P. Jacobsen et al., GENETIC AND NONGENETIC RISK-FACTORS FOR PROGRESSION OF DIABETIC NEPHROPATHY IN NORMOTENSIVE TYPE-1 PATIENTS, Diabetologia, 41, 1998, pp. 1145-1145
Authors:
HOVIND P
TARNOW L
OSTERGAARD PB
PARVING HH
Citation: P. Hovind et al., ELEVATED VASCULAR ENDOTHELIAL GROWTH-FACTOR IN TYPE-I DIABETIC-PATIENTS WITH DIABETIC NEPHROPATHY, Diabetologia, 41, 1998, pp. 1228-1228
Authors:
KNUDSEN E
GALL MA
ROSSING P
NIELSEN FS
PARVING HH
Citation: E. Knudsen et al., PLASMA-FIBRINOGEN LEVELS AND MORTALITY IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS, Diabetologia, 41, 1998, pp. 1355-1355
Authors:
GALL MA
KNUDSEN E
HOUGAARD P
BORCHJOHNSEN K
PARVING HH
Citation: Ma. Gall et al., PREDICTORS OF 10-YEAR MORTALITY IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS, Diabetologia, 41, 1998, pp. 1356-1356
Authors:
FAGERUDD JA
TARNOW L
JACOBSEN P
STENMAN S
NIELSEN FS
PETTERSSONFERNHOLM KJ
GRONHAGENRISKA C
PARVING HH
GROOP PH
Citation: Ja. Fagerudd et al., PREDISPOSITION TO ESSENTIAL-HYPERTENSION AND DEVELOPMENT OF DIABETIC NEPHROPATHY IN IDDM PATIENTS, Diabetes, 47(3), 1998, pp. 439-444
Authors:
PARVING HH
Citation: Hh. Parving, CALCIUM-ANTAGONISTS AND CARDIOVASCULAR RISK IN DIABETES, The American journal of cardiology, 82(9B), 1998, pp. 42-44
Authors:
PARVING HH
Citation: Hh. Parving, DIABETIC HYPERTENSIVE PATIENTS - A GROUP IN NEED OF PARTICULAR CARE AND ATTENTION, International journal of clinical practice, 1997, pp. 13-18